Literature DB >> 11994321

Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.

Enrico Papini1, Rinaldo Guglielmi, Antonio Bianchini, Anna Crescenzi, Silvia Taccogna, Francesco Nardi, Claudio Panunzi, Roberta Rinaldi, Vincenzo Toscano, Claudio M Pacella.   

Abstract

The aim of the study was to correlate the sonographic [ultrasound (US)] and color-Doppler (CFD) findings with the results of US-guided fine needle aspiration biopsy (FNA) and of pathologic staging of resected carcinomas to establish: 1) the relative importance of US features as risk factors of malignancy; and 2) a cost-effective management of nonpalpable thyroid nodules. Four hundred ninety-four consecutive patients with nonpalpable thyroid nodules (8-15 mm) were evaluated by US, CFD, and US-FNA. Ninety-two patients with inadequate cytology were excluded from the study. All patients with suspicious or malignant cytology underwent surgery, whereas subjects with benign cytology had clinical and US control 6 months later. Thyroid malignancies were observed in 18 of 195 (9.2%) solitary thyroid nodules and in 13 of 207 (6.3%) multinodular goiters. Cancer prevalence was similar in nodules greater or smaller than 10 mm (9.1 vs. 7.0%). Extracapsular growth (pT(4)) was present in 35.5%, and nodal involvement in 19.4% of neoplastic lesions, with no significant differences between tumors greater or smaller than 10 mm. At US cancers presented a solid hypoechoic appearance in 87% of cases, irregular or blurred margins in 77.4%, an intranodular vascular pattern in 74.2%, and microcalcifications in 29.0%. Irregular margins (RR 16.83), intranodular vascular spots (RR 14.29), and microcalcifications (RR 4.97) were independent risk factors of malignancy. FNA performed on hypoechoic nodules with at least one risk factor was able to identify 87% of the cancers at the expence of cytological evaluation of 38.4% of nonpalpable lesions. The majority of nonpalpable thyroid tumors can be identified by cytological evaluation of lesions presenting hypoechoic appearance in conjunction with one independent risk factor. Due to the nonnegligible prevalence of extracapsular growth and nodal metastasis, US-FNA should be performed on all 8-15 mm hypoechoic nodules with irregular margins, intranodular vascular spots or microcalcifications. Nonpalpable lesions of the thyroid without risk factors should be followed by means of clinical and US evaluation.

Entities:  

Mesh:

Year:  2002        PMID: 11994321     DOI: 10.1210/jcem.87.5.8504

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  282 in total

1.  The dilemma of non-palpable thyroid nodules.

Authors:  E Papini
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

2.  Clinical relevance of non-palpable thyroid nodules as assessed by ultrasound-guided fine needle aspiration biopsy.

Authors:  D Nabriski; R Ness-Abramof; T O Brosh; O Konen; M S Shapiro; L Shenkman
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 3.  Thyroid ultrasound as a predicator of thyroid disease.

Authors:  P Vitti; T Rago
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

4.  Ultrasound-based diagnostic classification for solid and partially cystic thyroid nodules.

Authors:  D W Kim; J S Park; H S In; H J Choo; J H Ryu; S J Jung
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

5.  Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.

Authors:  Ursula Nemec; Stefan F Nemec; Clemens Novotny; Michael Weber; Christian Czerny; Christian R Krestan
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

6.  Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.

Authors:  E Papini; R Negro; A Pinchera; R Guglielmi; A Baroli; P Beck-Peccoz; P Garofalo; M P Pisoni; M Zini; R Elisei; L Chiovato
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

7.  Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism.

Authors:  Dilek Berker; Serhat Isik; Ufuk Ozuguz; Yasemin Ates Tutuncu; Kerim Kucukler; Gulhan Akbaba; Yusuf Aydin; Serdar Guler
Journal:  Endocrine       Date:  2011-02       Impact factor: 3.633

8.  Diagnostic value of elastosonographically determined strain index in the differential diagnosis of benign and malignant thyroid nodules.

Authors:  Bekir Cakir; Cevdet Aydin; Birol Korukluoğlu; Didem Ozdemir; I Cagatay Sisman; Dilek Tüzün; Ayten Oguz; Gülnur Güler; Güven Güney; Ahmet Kuşdemir; S Yavuz Sanisoglu; Reyhan Ersoy
Journal:  Endocrine       Date:  2010-11-15       Impact factor: 3.633

9.  Diagnostic value of ultrasonography and TI-201/Tc-99m dual scintigraphy in differentiating between benign and malignant thyroid nodules.

Authors:  Ken Watanabe; Takao Igarashi; Hirokazu Ashida; Sho Ogiwara; Tomoyuki Ohta; Mayuki Uchiyama; Hiroya Ojiri
Journal:  Endocrine       Date:  2018-10-01       Impact factor: 3.633

10.  Ensuring patient safety when implementing a new diagnostic pathway for thyroid nodules.

Authors:  M Brimioulle; A Al-Lami; S Marzouk; H Emerson; A Balfour; V Dhar; I J Nixon
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.